vs
Side-by-side financial comparison of Claritev Corp (CTEV) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $246.6M, roughly 1.6× Claritev Corp). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs -32.7%, a 37.9% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
CTEV vs GRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $246.6M | $397.6M |
| Net Profit | $-80.6M | $20.9M |
| Gross Margin | — | 21.5% |
| Operating Margin | -3.1% | 7.7% |
| Net Margin | -32.7% | 5.3% |
| Revenue YoY | 6.2% | — |
| Net Profit YoY | 41.6% | — |
| EPS (diluted) | $-4.88 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $246.6M | $397.6M | ||
| Q3 25 | $246.0M | $377.4M | ||
| Q2 25 | $241.6M | $344.3M | ||
| Q1 25 | $231.3M | $329.3M | ||
| Q4 24 | $232.1M | — | ||
| Q3 24 | $230.5M | $314.4M | ||
| Q2 24 | $233.5M | — | ||
| Q1 24 | $234.5M | — |
| Q4 25 | $-80.6M | $20.9M | ||
| Q3 25 | $-69.8M | $9.8M | ||
| Q2 25 | $-62.6M | $9.0M | ||
| Q1 25 | $-71.3M | $9.4M | ||
| Q4 24 | $-138.0M | — | ||
| Q3 24 | $-391.4M | $-122.0M | ||
| Q2 24 | $-576.7M | — | ||
| Q1 24 | $-539.7M | — |
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 19.4% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -3.1% | 7.7% | ||
| Q3 25 | 4.1% | 4.3% | ||
| Q2 25 | 6.9% | 3.7% | ||
| Q1 25 | 4.2% | 3.9% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | -146.7% | -33.3% | ||
| Q2 24 | -224.4% | — | ||
| Q1 24 | -207.4% | — |
| Q4 25 | -32.7% | 5.3% | ||
| Q3 25 | -28.4% | 2.6% | ||
| Q2 25 | -25.9% | 2.6% | ||
| Q1 25 | -30.8% | 2.9% | ||
| Q4 24 | -59.4% | — | ||
| Q3 24 | -169.8% | -38.8% | ||
| Q2 24 | -247.0% | — | ||
| Q1 24 | -230.1% | — |
| Q4 25 | $-4.88 | — | ||
| Q3 25 | $-4.23 | — | ||
| Q2 25 | $-3.81 | — | ||
| Q1 25 | $-4.38 | — | ||
| Q4 24 | $-8.49 | — | ||
| Q3 24 | $-24.25 | — | ||
| Q2 24 | $-35.78 | — | ||
| Q1 24 | $-33.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.8M | $65.6M |
| Total DebtLower is stronger | $4.6B | $0 |
| Stockholders' EquityBook value | $-173.9M | $217.9M |
| Total Assets | $4.9B | $412.7M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.8M | $65.6M | ||
| Q3 25 | $39.2M | $36.5M | ||
| Q2 25 | $56.4M | $18.8M | ||
| Q1 25 | $23.1M | $14.0M | ||
| Q4 24 | $16.8M | — | ||
| Q3 24 | $86.6M | $37.2M | ||
| Q2 24 | $48.8M | — | ||
| Q1 24 | $58.7M | — |
| Q4 25 | $4.6B | $0 | ||
| Q3 25 | $4.5B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.5B | $34.3M | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.5B | — |
| Q4 25 | $-173.9M | $217.9M | ||
| Q3 25 | $-101.8M | $195.5M | ||
| Q2 25 | $-39.9M | $179.7M | ||
| Q1 25 | $14.8M | $163.2M | ||
| Q4 24 | $84.0M | — | ||
| Q3 24 | $207.6M | $133.9M | ||
| Q2 24 | $603.4M | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | $4.9B | $412.7M | ||
| Q3 25 | $5.0B | $390.0M | ||
| Q2 25 | $5.1B | $356.3M | ||
| Q1 25 | $5.1B | $334.0M | ||
| Q4 24 | $5.2B | — | ||
| Q3 24 | $5.3B | $348.0M | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $6.4B | — |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 304.87× | — | ||
| Q4 24 | 53.67× | — | ||
| Q3 24 | 21.73× | 0.26× | ||
| Q2 24 | 7.48× | — | ||
| Q1 24 | 3.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.3M | $34.6M |
| Free Cash FlowOCF − Capex | $36.4M | — |
| FCF MarginFCF / Revenue | 14.8% | — |
| Capex IntensityCapex / Revenue | 12.1% | — |
| Cash ConversionOCF / Net Profit | — | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-12.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.3M | $34.6M | ||
| Q3 25 | $19.9M | $28.2M | ||
| Q2 25 | $61.2M | $19.9M | ||
| Q1 25 | $-30.1M | $17.6M | ||
| Q4 24 | $-33.4M | — | ||
| Q3 24 | $72.8M | — | ||
| Q2 24 | $18.5M | — | ||
| Q1 24 | $49.7M | — |
| Q4 25 | $36.4M | — | ||
| Q3 25 | $-16.3M | $24.2M | ||
| Q2 25 | $36.6M | — | ||
| Q1 25 | $-68.9M | — | ||
| Q4 24 | $-63.8M | — | ||
| Q3 24 | $41.1M | — | ||
| Q2 24 | $-7.0M | — | ||
| Q1 24 | $19.2M | — |
| Q4 25 | 14.8% | — | ||
| Q3 25 | -6.6% | 6.4% | ||
| Q2 25 | 15.2% | — | ||
| Q1 25 | -29.8% | — | ||
| Q4 24 | -27.5% | — | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | -3.0% | — | ||
| Q1 24 | 8.2% | — |
| Q4 25 | 12.1% | — | ||
| Q3 25 | 14.7% | 1.1% | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 16.8% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 10.9% | — | ||
| Q1 24 | 13.0% | — |
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.86× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
